参考文献/References:
[1] Schcena M,Shalon D,Davis W,et al.Quantitative monitoring of gene expression patterns with a complementary DNA microarray[J].Science,1995,270(5235):467-470.
[2] Wilson M,DeRisi J,Kristensen HH,et al.Exploring drug-induced alterations in gene expression in mycobacterium tuberculosis by microarray hybridization[J].Proc Natl Acad Sci USA,1999,96(22):12833.
[3] Afshari CA,Nuwaysir EF,Barrett JC.Application of complementary DNA microarray technology to carcinogen identification,toxicology,and drug safety evaluation[J].Cancer Res,1999,59(19):4759-4760.
[4] Medlin JF.Timely toxicology[J].Environ Health Perspect,1999,107(5):A256-A258.
[5] Amundson SA,Bittner M,Chen Y,et al.Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses[J].Oncogene,1999,18(24):3666-3672.
[6] Schena M,Heller RA,Theriault TP,et al.Microarrays:biotechnologys discovery platform for functional genomics[J].TIB Tech,1998,16(3):301-306.
[7] Schummer M,Ng W,Nelson PS,et al.Inhexpensive handheld device for the construction of high-densitynucleic acid arrays[J].Biol Tech,1997,23(6):1087.
[8] MatsonRS,Rampal J,Pentoney SL,et al.Biopolymer synthesis on polypropylene supports:oligonucleotide arrays[J].Anal Biochem,1995,224(1):110.
[9] Brazma A,Vilo J.Gene expression data analysis[J].FEBS Lett,2000,480(1):17-24.
[10] SchenaM,Heller RA,Theriault TP,et al.Microarrays biotechnologys discovery platform for functional genomics[J].TIB Tech,1998,16(3):301-306.
[11] Editorial.Getting hip to chip[J].Nature Genet.1998,18(3):195.
[12] DeRilsi J,Penland L,Brown PO,et al.Use of a cDNA microarray to analysis gene expression patterns in human cancer[J].Nature Genet,1996,14(4):457-460.
[13] Lipshutz D,Morris D,Chee M,et al.Using oligonucleotide probe arrays to access genetic diversity[J].Biol Tech,1995,19(3):442-447.
[14] Chee M,Yang R,Hubbell E,et al.Accessing genetics information with hig-density DNA arrays[J].Science,1996,274(5287):610-614.
[15] Hacia JG,Brody LC,Chee M S,et al.Detection of heterozygous mutations in BRCA 1 using high density oligonucleotide arrays and two-colour fluorescence analysis[J].Nature Genet,1996,14(4):441-447.
[16] Hacia JG,Makalowski W,Edgemon K,et al.Evolutionary sequence comparisons using high-density oligonucleotide arrays[J].Nature Genet,1998,18(3):155-158.
[17] Brown P,Hartwell L.Genomics and human disease-variations on variation[J].Nature Genet,1998,18(1):91-93.
[18] Gress TM,Muller-Pillasch F,Geng M,et al.A pancreatic cancer-specific expression profile[J].Oncogene,1996,13(8):1819-1830.
[19] Ramsayg G.DN A chips:state of the art[J].Nature Biotechnol,1998,16(1):40-44.
[20] Griffin TJ,Tang W,Smith LM.Genetic analysis by peptide nucleic acid affinity MALDI-TOF mass spectrometry[J].Nature Biotechnol,1997,15(3):1368.
[21] Cox R.The multi-step nature of carcinogenesis and the implications for risk analysis[J].Int J Radiat,1998,73(4):373-376.